Это краткое руководство содержит рекомендации по поэтапному переходу к новым рекомендованным ВОЗ схемам лечения ВИЧ-инфекции. Целевая аудитория: руководители страновых программ противодействия ВИЧ-инфекции, закупочные агентства, партнеры по реализации программ, и другие заинтересованные стороны. Цель этого документа – обеспечить бесперебойные поставки антиретровирусных (АРВ) препаратов; безопасно, быстро и ...
Antiretroviral therapy (ART) for the treatment of HIV infection has improved steadily since the advent of potent combination therapy in 1996. ART has dramatically reduced HIV-associated morbidity and mortality and has transformed HIV infection into a manageable chronic condition. In addition, ART is highly effective ...
Fast-Track is a comprehensive approach implemented by health systems working in close collaboration with civil society to deliver evidenceinformed, high-impact services within an enabling environment that protects individual rights and moves society towards the goal of zero discrimination. Fast-Track is guided at the national level ...
Early initiation of ART in patients with CD4+ T-cell counts of less than 50 per cubic millimeter increased AIDS-free survival. Deferral of the initiation of ART to the first 4 weeks of the continuation phase of tuberculosis therapy in those with higher CD4+ T-cell counts ...
With this update of the consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, WHO, for the first time, recommends that all people living with HIV be provided with antiretroviral therapy (ART). This will bring us one step closer to ...
HIV testing is the gateway to HIV prevention, treatment, care and other support services. The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organisation (WHO) have endorsed global goals to achieve “zero new HIV infections, zero discrimination and zero AIDS-related deaths” by ...
Forging a Path to 90-90-90: Launch of WHO Guidelines on HIV Testing Services and UNAIDS/WHO Guidelines on Conducting National Population-based HIV Surveys
WHO guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection provide a public health approach for scaling up HIV care and treatment programmes and focus on simplified, harmonized and effective antiretroviral therapy (ART) regimens for use in resource-limited settings. In ...
People reach HIV treatment, care, and the full range of prevention options through the gateway of HIV testing and counselling (HTC). Currently, most people with HIV do not know that they are infected; those who do know often test late; and poor linkages from HTC ...
Настоящее сводное руководство содержит новые рекомендации по диагностике инфекции, вызываемой вирусом иммунодефицита человека (ВИЧ), оказанию помощи людям, живущим с ВИЧ, и использованию антиретровирусных (АРВ) препаратов для лечения и профилактики ВИЧ-инфекции. Эти рекомендации касаются всех этапов оказания помощи при ВИЧ-инфекции, включая тестирование, уход и лечение. В ...
Новое сводное руководство по вопросам профилактики, диагностики, лечения и ухода в связи с ВИЧ-инфекцией для ключевых групп населения объединяет все существующие руководящие указания Всемирной организации здравоохранения (ВОЗ), относящиеся к следующим пяти группам населения, которые имеют ключевое значение для действий по борьбе с ВИЧ.
Эти группы следующие: ...
WHO guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection provide a public health approach for scaling up HIV care and treatment programmes and focus on simplified, harmonized and effective antiretroviral therapy (ART) regimens for use in resource-limited settings. In ...
In 2013, WHO released new treatment recommendations that expand the number of people eligible for treatment. The groups newly eligible for treatment include the following: all HIV-infected pregnant women, HIV-infected adults with hepatitis B infection and severe liver disease, serodiscordant couples, adults with CD4þ T-cell ...
Efavirenz is one of the most widely used nonnucleoside reverse transcriptase inhibitors (NNRTIs) in first-line antiretroviral therapy (ART) and is recommended as a preferred option in adult treatment guidelines. However, data from primate studies and some human case reports have raised concern regarding a association ...
Antiretroviral treatment (ART) has converted a highly fatal HIV infection into a chronic condition that requires lifelong care. Within the past decade, worldwide access to ART has improved significantly, with almost 10 million people receiving ART by the end of 2012. In addition to its ...
Global efforts to scale up antiretroviral therapy (ART) between 2002 and 2012 averted an estimated 4.2 million deaths in low-income and middle-income countries. The United Nations endorsed the importance of this impact and agreed to scale up ART to 15 million people by 2015. In ...
Aims of the new WHO HTS guidelines
Addressing the testing gap
Getting testing out intocommunities
Supporting better linkage
Better focus and appropriate targeting
Improving quality to prevent misdiagnosis
The optimal timing for initiating antiretroviral therapy (ART) in individuals infected with HIV-1 has not yet been resolved. The US Department of Health and Human Services and the International Antiviral Society – USA recommend starting ART as close to diagnosis as possible. France and Brazil ...
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
